Genmab A/S
CSE:GMAB

Watchlist Manager
Genmab A/S Logo
Genmab A/S
CSE:GMAB
Watchlist
Price: 1 534.5 DKK -1.35% Market Closed
Market Cap: 101B DKK
Have any thoughts about
Genmab A/S?
Write Note

Genmab A/S
Accounts Receivables

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Genmab A/S
Accounts Receivables Peer Comparison

Comparables:
ZEAL
ASND
B
BAVA
F
FLUO
BIOPOR

Competitive Accounts Receivables Analysis
Latest Figures & CAGR of Competitors

Company Accounts Receivables CAGR 3Y CAGR 5Y CAGR 10Y
Genmab A/S
CSE:GMAB
Accounts Receivables
kr6.2B
CAGR 3-Years
36%
CAGR 5-Years
48%
CAGR 10-Years
52%
Zealand Pharma A/S
CSE:ZEAL
Accounts Receivables
kr203.1m
CAGR 3-Years
27%
CAGR 5-Years
527%
CAGR 10-Years
N/A
Ascendis Pharma A/S
NASDAQ:ASND
Accounts Receivables
€49.2m
CAGR 3-Years
397%
CAGR 5-Years
N/A
CAGR 10-Years
37%
B
Bavarian Nordic A/S
CSE:BAVA
Accounts Receivables
kr1.1B
CAGR 3-Years
46%
CAGR 5-Years
65%
CAGR 10-Years
26%
F
Fluoguide AS
STO:FLUO
Accounts Receivables
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bioporto A/S
CSE:BIOPOR
Accounts Receivables
kr4.5m
CAGR 3-Years
-15%
CAGR 5-Years
-9%
CAGR 10-Years
N/A

See Also

What is Genmab A/S's Accounts Receivables?
Accounts Receivables
6.2B DKK

Based on the financial report for Jun 30, 2024, Genmab A/S's Accounts Receivables amounts to 6.2B DKK.

What is Genmab A/S's Accounts Receivables growth rate?
Accounts Receivables CAGR 10Y
52%

Over the last year, the Accounts Receivables growth was 32%. The average annual Accounts Receivables growth rates for Genmab A/S have been 36% over the past three years , 48% over the past five years , and 52% over the past ten years .

Back to Top